Neurocrine Biosciences (NBIX) Misses Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $137.82 -0.81%
Revenue Growth %: +30.8%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +30.8%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.40), $0.15 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- KeyBanc gets bearish on Comcast as broadband competition intensifies
- Costco Wholesale (COST) PT Raised to $1,040 at DA Davidson Following Q4 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
